AI News NQ Analysis

[Sheng Ta] February 2026 Monthly Revenue NT$466 Million (YoY -16.4%)

NQ Score 63/100
N1 Content Completeness 8

AI Summary (NQ-processed)

Sheng Ta (1720) released its financial report, showing that its February 2026 monthly revenue was NT$466 million, a 16.4% decrease compared to the same period last year. As a pharmaceutical company in the biotechnology and healthcare industry, its revenue performance may be affected by drug shipment schedules and market demand.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What was Sheng Ta's total revenue for February 2026?
A: Sheng Ta's total revenue for February 2026 was NT$466 million.
Q: How did Sheng Ta's February 2026 revenue compare to the same month last year?
A: Sheng Ta's February 2026 revenue experienced a year-over-year decrease of 16.4%.
Q: What is the company code for Sheng Ta?
A: The company code for Sheng Ta is 1720.
Q: In which industry sector does Sheng Ta operate?
A: Sheng Ta operates within the Biotechnology and Healthcare industry sector.
Q: What was the exact revenue figure in thousands of NTD for Sheng Ta in February 2026?
A: The exact revenue figure for Sheng Ta in February 2026 was 466,104 thousand NTD.